A detailed history of Contravisory Investment Management, Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Contravisory Investment Management, Inc. holds 6,789 shares of BSX stock, worth $694,922. This represents 0.14% of its overall portfolio holdings.

Number of Shares
6,789
Previous 7,473 9.15%
Holding current value
$694,922
Previous $626,000 3.19%
% of portfolio
0.14%
Previous 0.14%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 14, 2025

SELL
$83.62 - $91.5 $57,196 - $62,586
-684 Reduced 9.15%
6,789 $606,000
Q3 2024

Oct 09, 2024

BUY
$72.96 - $84.0 $23,566 - $27,132
323 Added 4.52%
7,473 $626,000
Q2 2024

Jul 10, 2024

SELL
$67.33 - $77.71 $19,862 - $22,924
-295 Reduced 3.96%
7,150 $550,000
Q1 2024

Apr 11, 2024

BUY
$57.6 - $68.62 $576 - $686
10 Added 0.13%
7,445 $509,000
Q4 2023

Jan 11, 2024

BUY
$48.64 - $57.81 $1,702 - $2,023
35 Added 0.47%
7,435 $429,000
Q3 2023

Oct 10, 2023

SELL
$50.19 - $54.68 $19,574 - $21,325
-390 Reduced 5.01%
7,400 $390,000
Q2 2023

Jul 12, 2023

BUY
$49.72 - $54.64 $387,318 - $425,645
7,790 New
7,790 $421,000
Q2 2020

Jul 09, 2020

SELL
$30.19 - $39.11 $60,047 - $77,789
-1,989 Closed
0 $0
Q1 2020

Apr 09, 2020

BUY
$25.83 - $45.71 $4,985 - $8,822
193 Added 10.75%
1,989 $65,000
Q4 2019

Jan 09, 2020

BUY
$37.87 - $45.37 $9,921 - $11,886
262 Added 17.08%
1,796 $81,000
Q3 2019

Oct 07, 2019

BUY
$40.31 - $43.45 $61,835 - $66,652
1,534 New
1,534 $62,000
Q4 2017

Jan 18, 2018

SELL
$24.79 - $29.8 $545 - $655
-22 Closed
0 $0
Q3 2017

Oct 12, 2017

BUY
$26.26 - $29.17 $577 - $641
22
22 $1,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $147B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Contravisory Investment Management, Inc. Portfolio

Follow Contravisory Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Contravisory Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Contravisory Investment Management, Inc. with notifications on news.